Bipolar III
Links shared publicly online about this topic
Bipolar Disorder on the Job | Bipolar Beat | Bipolar Beat
blogs.psychcentral.com — “Dr. Candida Fink MD explains how to talk about bipolar disorder in the workplace with supervisors and coworkers in a productive way.” View full resource at blogs.psychcentral.com
Most Recently Shared on December 22, 2009 at 10:46 am By:
Bipolar Beat: Bipolar on the Job Part III: How to Talk About Bipolar Disorder http://bit.ly/6Upzq4
Test for Genetic Risk of Bipolar | Psych Central News
psychcentral.com — “A genetic test for bipolar disorder is on the horizon say researchers from Indiana University School of Medicine. The scientists published a prototype for” View full resource at psychcentral.com
Most Recently Shared on April 14, 2010 at 12:02 pm By:
News: Test for Genetic Risk of Bipolar http://bit.ly/9gN9S2
Does Mel Gibson Really Have Bipolar Disorder? - Bipolar Disorder Center - Everyday Health
everydayhealth.com — “Could Mel Gibson's rants and tirades be signs of bipolar disorder, and is that an excuse for his bad behavior? Learn the facts about bipolar disorder.” View full resource at everydayhealth.com
Most Recently Shared on September 28, 2010 at 10:40 pm By:
Is #MelGibson really #bipolar, or just a jerk? http://ow.ly/2LcAH
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from a Phase III clinical trial of cariprazine , an investigatio” View full resource at finance.yahoo.com
Most Recently Shared on February 8, 2012 at 9:00 am By:
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational ..... http://t.co/94WVpuPV
PolygenicBlog: Novartis Phase III Study Shows Meningococcal B Vaccine Candidate Could Be First To Provide Broad Coverage Against Deadly Disease
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on September 14, 2010 at 12:16 am By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter Pharmacist, PhD, Doctor, and Medical Technology
Novartis Phase III Study Shows Meningococcal B Vaccine Candidate Could Be First To Provide… http://goo.gl/fb/4qit5
Positive Results on Forest/Gedeon Drug - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Preliminary top-line results were presented from a phase III study of cariprazine that was conducted in patients with acute mania associated with bipolar I disorder.” View full resource at finance.yahoo.com
Most Recently Shared on February 10, 2012 at 3:09 am By:
Positive Results on Forest/Gedeon Drug: Preliminary top-line results were presented from a phase III study of ca... http://t.co/mIeie8pG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Psych Central
Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.
-
Psych Central
Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.
-
Everyday Health
Everyday Health inspires your health goals and supports your progress through expert guidance and breaking health news. Tweets managed by @anniehauser
Advertisement
